Skip to main content
$4.83 -$0.77 (-13.8%)

04:00 PM EST on 02/25/21

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $4.83 Mkt Cap $254.1M
Open $5.44 P/E Ratio 0.00
Prev. Close $4.83 Div. (Yield) $0.00 (0.0%)
Daily Range $4.75 - $5.53 Volume 1,889,263
52-Wk Range $2.04 - $7.02 Avg. Daily Vol. 961,510

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

148 Outperform
72 Underperform
 

All-Star Players

14 Outperform
21 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (65.19)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: +358.71

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -106.75

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (65.19) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +203.82

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (30.65) Score: +824.01

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
beecha 75.94 9/19/2017 Outperform 5Y $0.60 +702.33% +52.93% +649.39 0 Comment
portefeuille3 98.00 12/27/2017 Outperform 5Y $0.66 +633.82% +42.95% +590.87 0 Comment
Paul8888888 < 20 1/26/2016 Outperform 5Y $0.86 +461.63% +102.91% +358.71 1 Comment
Spelunkin 49.45 11/3/2009 Underperform 5Y $10.39 -53.51% +268.55% +322.06 0 Comment
TrackDuality 25.81 11/6/2009 Underperform 5Y $11.89 -59.38% +259.81% +319.18 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -51.21% +267.17% +318.38 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -51.21% +267.17% +318.38 0 Comment
MSFOBV1YH 98.57 11/4/2009 Underperform 5Y $10.93 -55.81% +262.36% +318.17 0 Comment
39272x4 26.99 11/9/2009 Underperform 5Y $12.00 -59.75% +254.17% +313.92 0 Comment
ModernDayWarrior 29.51 10/29/2009 Underperform 5Y $9.58 -49.58% +263.47% +313.05 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.